Halozyme Therapeutics shares owned by Radnor Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Radnor Capital Management
from 13F filings
Historical chart of Radnor Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Radnor Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Radnor Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $347k | 4.4k | 78.27 |